(Q34129408)

31 July 2017

title

Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis (English)

1 reference

31 July 2017

1 reference

7

I Ray-Coquard

0 references

Axel Le Cesne

4

object named as

A Le Cesne

0 references

Jean-Yves Blay

14

object named as

J Y Blay

0 references

M Tubiana-Hulin

6

object named as

M Tubiana-Hulin

1 reference

31 July 2017

A Dufresne

1

1 reference

31 July 2017

F Bertucci

2

1 reference

31 July 2017

N Penel

3

1 reference

31 July 2017

B Bui

5

1 reference

31 July 2017

D Cupissol

8

1 reference

31 July 2017

C Chevreau

9

1 reference

31 July 2017

D Perol

10

1 reference

31 July 2017

A Goncalves

11

1 reference

31 July 2017

M Jimenez

12

1 reference

31 July 2017

P P Bringuier

13

1 reference

31 July 2017

language of work or name

English

0 references

publication date

27 July 2010

1 reference

British Journal of Cancer

31 July 2017

published in

1 reference

31 July 2017

volume

103

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

482-485

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605783

31 July 2017

exact match

0 references

cites work

A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939782

KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939782

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939782

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939782

The pharmacological treatment of aggressive fibromatosis: a systematic review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939782

Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2939782

Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment.

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605783

Response of extraabdominal desmoid tumors to therapy with imatinib mesylate

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605783

Re: Response of a KIT-Positive Extra-abdominal Fibromatosis to Imatinib Mesylate and KIT Genetic Analysis

21 January 2018

1 reference

12 December 2020

Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis

1 reference

12 December 2020

Desmoid-type fibromatosis

1 reference

12 December 2020

Desmoid-type fibromatoses involving the brachial plexus: treatment options and assessment of c-KIT mutational status

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6605783

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference